Kilian Schober
- Immunology top 10%
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 17
- Immunotherapy and Immune Responses 4
- Oncology top 10%
- CAR-T cell therapy research 24
-
- Virus-based gene therapy research 5
-
- CRISPR and Genetic Engineering 6
-
- Cytomegalovirus and herpesvirus research 7
-
- Nanowire Synthesis and Applications 6
- Co-authors
- Dirk H. BuschThomas MüllerSimon GrassmannVeit R. BuchholzManuel EffenbergerElvira D’IppolitoKathrin SchumannMateusz P. Poltorak
- Cited by
- ImmunologyOncologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nature Communications (2 papers)Blood (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Kilian Schober
37 papers receiving 768 citations
Peers
Comparison fields: 5 of 69
- Immunology 371
- Oncology 442
- Genetics 154
- Infectious Diseases 68
- Molecular Biology 251
Countries citing papers authored by Kilian Schober
This map shows the geographic impact of Kilian Schober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kilian Schober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kilian Schober more than expected).
Fields of papers citing papers by Kilian Schober
This network shows the impact of papers produced by Kilian Schober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kilian Schober. The network helps show where Kilian Schober may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kilian Schober, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 15 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 28 | |
| 7 | 2023 | 23 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 24 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 20 | |
| 12 | 2022 | 2 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 4 | |
| 16 | 2020 | 37 | |
| 17 | 2019 | 20 | |
| 18 | 2019 | 115 | |
| 19 | 2018 | 28 | |
| 20 | 2017 | 20 |
About Kilian Schober
Kilian Schober is a scholar working on Immunology, Oncology and Epidemiology, having authored 38 papers that have together received 776 indexed citations. Recurring topics across this work include CAR-T cell therapy research (24 papers), Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (17 papers), Cytomegalovirus and herpesvirus research (7 papers), CRISPR and Genetic Engineering (6 papers), Nanowire Synthesis and Applications (6 papers), Virus-based gene therapy research (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (371 citations), Oncology (442 citations) and Genetics (154 citations). Kilian Schober has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Dirk H. Busch, Thomas Müller, Simon Grassmann, Veit R. Buchholz, Manuel Effenberger, Elvira D’Ippolito, Kathrin Schumann, Mateusz P. Poltorak, Christian Stemberger and Alexander Marson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.